NCT03238742

The Efficacy of Xuebijing Injection on Sepsis

The Efficacy of Xuebijing Injection in Adult Patients With Sepsis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,817 (actual)
• Sponsor: Southeast University, China · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The Efficacy of Xuebijing Injection in Adult Patients with Sepsis

Detailed description

The purpose of this placebo-controlled study is to determine if Xuebijing Injection treatment provides significant mortality reduction improvement in patients with sepsis compared with placebo treatment in patients receiving the current standard of care for sepsis. This study will also assess the effectiveness of Xuebijing Injection in reducing 28-day mortality in patients with sepsis.

Conditions

• Sepsis

Interventions

Type	Name	Description
DRUG	Xuebijing Injection	100ml Xuebijing Injection every 12 hours for 5 days
DRUG	normal saline	200ml normal saline every 12 hours for 5 days

Timeline

• Start date: 2017-10-20
• Primary completion: 2019-07-28
• Completion: 2020-01-08
• First posted: 2017-08-03
• Last updated: 2021-01-05

Locations

1 site across 1 country: China